PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumorsMónica Tang, Michael Friedländer, Rachel O’Connell et al.|Gynecologic Oncology|2019Cited by 88
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsyPaul A. Cohen, C. David Wrede, Max Bulsara et al.|Gynecologic Oncology|2020Cited by 9
Excisional treatment in women with cervical adenocarcinoma in situ (AIS): a prospective randomised controlled non-inferiority trial to compare AIS persistence/recurrence after loop electrosurgical excision procedure with cold knife cone biopsy: protocol for a pilot studyPaul A. Cohen, Pennie Stoyles, Alison H. Brand et al.|BMJ Open|2017Cited by 5
<u>Ex</u>cisional Treatment&nbsp; <u>C</u>omparison For&nbsp; <u>I</u>n&nbsp; <u>S</u>itu&nbsp; <u>E</u>ndocervical Adenocarcinoma (EXCISE): A Phase 2 Pilot Randomised Controlled Trial to Compare Histopathological Margins Status, Specimen Size and Fragmentation after Loop Electrosurgical Excision Procedure and Cold Knife Cone BiopsyPaul A. Cohen, C. David Wrede, Yee Leung et al.|SSRN Electronic Journal|2020Cited by 0